Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Rosacea Clinical Trials
Rosacea clinical trials are recruiting across 5 cities. Here are the cities with the most active studies:
Rosacea Trial Phases
5 research organizations are sponsoring rosacea trials.
About Rosacea
Rosacea is a chronic skin condition that causes redness, visible blood vessels, and sometimes small bumps on the face. It primarily affects middle-aged women with fair skin. Treatment includes topical and oral medications, laser therapy, and trigger avoidance.
Clinical trials are advancing new treatments for rosacea. Currently, 6 studies are recruiting a combined 342 participants across the United States. Research is being conducted by 5 organizations including Integrative Skin Science and Research, Novartis Pharmaceuticals, Wright State University and 2 others.
2026 Rosacea Research Landscape
As of July 2026, the rosacea clinical trial landscape includes 6 actively recruiting studies across 5 cities in the United States. These studies are collectively seeking 342 participants, with an average enrollment target of 57 per study.
The research spans multiple phases of development: 3 studies are in NA, 3 studies are in PHASE2.
Research is being led by 5 different organizations, including Integrative Skin Science and Research, Novartis Pharmaceuticals, Wright State University, University of Miami, Narrows Institute for Biomedical Research.
Geographically, rosacea trials are most concentrated in Sacramento, California (2 trials); El Paso, Texas (1 trial); Fairborn, Ohio (1 trial); Miami Beach, Florida (1 trial); Brooklyn, New York (1 trial).
Featured Rosacea Studies
Highlighted recruiting studies for rosacea, selected by enrollment size and research scope.
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
The study is conducted to determine if image-based computer grading can of acne, melasma, rosacea and seborrheic dermatitis correlate well to expert based clinical severity grading.
A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)
This Phase 2 study aims to evaluate whether Bruton's tyrosine kinase (BTK) inhibition with remibrutinib can produce a clinically meaningful reduction in inflammatory lesions in adults with moderate-to-severe papulopustular rosacea, while also assessing safety and tolerability of remibrutinib in this indication.
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea.
Frequently Asked Questions About Rosacea Clinical Trials
Are there rosacea clinical trials near me?
Yes, there are 6 rosacea clinical trials currently recruiting across 5+ cities in the United States, including Sacramento, California; El Paso, Texas; Fairborn, Ohio. Browse the studies above to find one at a location convenient for you.
How do I join a rosacea clinical trial?
To join a rosacea clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are rosacea clinical trials free?
Yes, participation in rosacea clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of rosacea treatments are being studied?
Current rosacea clinical trials are testing a range of approaches across NA (3 studies), PHASE2 (3 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 5 research organizations.
Is it safe to participate in rosacea clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov